Poppins

The company provides a Class I digital medical device designed to support children aged 7 to 11 with severe dyslexia. The product uses rhythmic training and musical video games to improve phonology, reading speed, and visual-attentional span through 20-minute daily sessions. It serves as a therapeutic relay for families and speech therapists, offering progress tracking and clinical validation to reinforce skills between professional appointments.